Circufiber Inc. has developed Circulight IR, a patent-pending infrared yarn that enhances vasodilation to improve blood circulation in the feet and lower legs. Their clinically proven diabetic socks are designed to reduce the risk of complications associated with poor circulation in individuals with diabetes.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with diabetes often experience poor blood circulation in their feet and lower legs, increasing the risk of complications such as foot ulcers, infections, and amputations. Traditional socks do not actively promote blood flow, leaving a need for solutions that enhance circulation and reduce these risks.
Solution
Circufiber Inc. offers diabetic socks featuring Circulight IR technology, a patent-pending infrared yarn designed to enhance vasodilation and improve blood circulation in the feet and lower legs. These socks are clinically proven to increase circulation, reduce the risk of complications associated with diabetes, and provide padding to reduce blisters, moisture, and pressure. Designed and made in the USA, Circufiber socks are recognized by the American Podiatric Medical Association (APMA) for promoting foot health and determined by the FDA to be general wellness medical devices.
Target Audience
The primary target audience includes individuals with diabetes seeking to improve blood circulation in their feet and lower legs, as well as those looking for comfortable and protective diabetic socks.
Features
- Circulight IR technology embedded in the yarn to enhance vasodilation
- Clinically proven at Yale School of Medicine to increase circulation in the feet and lower legs
- Padding designed to reduce blisters, moisture, and pressure
- Made in the USA to ensure high quality and manufacturing control
- Recognized by the American Podiatric Medical Association (APMA)
- FDA determined as general wellness medical devices
- 30-day money-back guarantee